INARI Satellite Symposium: What makes INARI’s lytic-free thrombectomy the first choice for acute PE and DVT treatment?

 

     
 
   

 

CIRSE Congress 2023. 9th – 13th September. Copenhagen, Denmark

 

Inari Medical logo
 
     
 

 

Satellite Symposium:

 

What makes INARI’s lytic-free thrombectomy the first choice for acute PE and DVT treatment?

 

 

 

Sunday 10th September | 13:00–14:00 | Auditorium 15

 

     
 

 

   
Dr Aaron DuCoffe

Dr Aaron DuCoffe

USA

 

Institutional experience in transforming the approach for HR PE patients

 

 
Dr Enrique Alejandre-Lafont

Dr Enrique Alejandre-Lafont

Switzerland

 

How proven predictors impact patient selection for the interventional treatment of IHR PE

 

 
Dr Andrew Wigham

Dr Andrew Wigham

UK

 

Expanding the treatment window for the effective management of DVT

 

 
Dr Andrew S. Niekamp

Dr Andrew S. Niekamp

USA

 

The importance of a hospital VTE programme for patients with acute PE and DVT

 

 
 
 
 
       

 

Mechanical Thrombectomy Hands-On Device Training

 

Monday 11th September
08:30–10:00 and 13:00–14:30
Hall A (HDT 1)

 

Join our expert to learn more about:

 

Dr Emma Wilton

 

Dr Emma Wilton

UK

 

     

 

  • ClotTriever® and FlowTriever® systems
  • The latest clinical studies: CLOUT, FLASH & FLAME
  • DVT and acute PE case studies

 

 
 
       

 

VTE Expert Talk

 

Dr Shon Chakrabarti

 

 

Dr Shon Chakrabarti

Vice President and General Manager,
Chronic Venous Therapies, Inari Medical Inc. US

       

 

Join Dr Shon Chakrabarti to discuss the advancements of care and treatment of acute Venous Thromboembolism patients, including:

 

  • Overview of latest cinical data on PE and DVT (FLAME and CLOUT 500)
  • Why consider the endovascular treatment of DVT?
  • Risk stratification
  • Long-term consequences of PE and DVT
  • Outcomes of lytic-free thrombectomy

 

 

Saturday 9th Sept.
14:30 – 15:30

 

Sunday 10th Sept.
10:30 – 11:30

 

Monday 11th Sept.
10:30 – 11:30

 

Click here to Register

 

 

     
 

 

www.inarimedical.com

 

 
     
 

 

ClotTriever® Intended Use

 

The ClotTriever® Thrombectomy System is indicated for the non-surgical removal of thrombi and emboli from blood vessels, and for injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel, for use in the lower peripheral vasculature, including Deep Vein Thrombosis.

 

Indications, Contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

 

FlowTriever® Intended Use

 

The FlowTriever® Retrieval/Aspiration System is indicated for (1) the non-surgical removal of emboli and thrombi from blood vessels; and (2) injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. The FlowTriever system is intended for use in the peripheral vasculature and for the treatment of pulmonary embolism.

 

Indications, Contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.

 

Caution: Federal (USA) law restricts these devices to sale by or on the order of a physician.
All trademarks are property of their respective owners.

 

Inari Medical, Inc. headquarters: 6001 Oak Canyon, Suite 100  |  Irvine CA 92618
Inari Medical Europe GmbH, a subsidiary of Inari Medical, Inc.  |  Messeplatz 10  |  4058 Basel, Switzerland